BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2475422)

  • 1. Clear cell metaplasia of the breast: a lesion showing eccrine differentiation.
    Viña M; Wells CA
    Histopathology; 1989 Jul; 15(1):85-92. PubMed ID: 2475422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ectopic breast tissue and breast-like sweat gland metaplasias: an overlapping spectrum of lesions.
    Pfeifer JD; Barr RJ; Wick MR
    J Cutan Pathol; 1999 Apr; 26(4):190-6. PubMed ID: 10335896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benign cutaneous adnexal tumors with combined folliculosebaceous, apocrine, and eccrine differentiation. Clinicopathologic and immunohistochemical study of eight cases.
    Wong TY; Suster S; Cheek RF; Mihm MC
    Am J Dermatopathol; 1996 Apr; 18(2):124-36. PubMed ID: 8739986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morphologic and functional aspects of apocrine metaplasia in dysplastic and neoplastic breast tissue.
    Bussolati G; Cattani MG; Gugliotta P; Patriarca E; Eusebi V
    Ann N Y Acad Sci; 1986; 464():262-74. PubMed ID: 3524352
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunohistochemistry of GCDFP-24 and zinc alpha2 glycoprotein in benign sweat gland tumors.
    Mazoujian G
    Am J Dermatopathol; 1990 Oct; 12(5):452-7. PubMed ID: 2244662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Syringoid eccrine carcinoma: a case report.
    Malmusi M; Collina G
    Am J Dermatopathol; 1997 Oct; 19(5):533-5. PubMed ID: 9335248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [An immunohistochemical study of normal sweat glands using an antibody to the breast cyst fluid protein (GCDFP-15)].
    Komatsu T; Tajima S; Nishikawa T
    Nihon Hifuka Gakkai Zasshi; 1989 Aug; 99(9):985-9. PubMed ID: 2689726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tubular apocrine adenoma and papillary eccrine adenoma. Entities or unity?
    Fox SB; Cotton DW
    Am J Dermatopathol; 1992 Apr; 14(2):149-54. PubMed ID: 1566975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spiradenoma and dermal cylindroma: comparative immunohistochemical analysis and histogenetic considerations.
    Meybehm M; Fischer HP
    Am J Dermatopathol; 1997 Apr; 19(2):154-61. PubMed ID: 9129700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apoeccrine glands in nevus sebaceus.
    van der Putte SC
    Am J Dermatopathol; 1994 Feb; 16(1):23-30. PubMed ID: 8160927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sebaceous gland metaplasia in intraductal papilloma of the breast.
    Jiao YF; Nakamura S; Oikawa T; Sugai T; Uesugi N
    Virchows Arch; 2001 May; 438(5):505-8. PubMed ID: 11407480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemistry of gross cystic disease fluid protein (GCDFP-15) in 65 benign sweat gland tumors of the skin.
    Mazoujian G; Margolis R
    Am J Dermatopathol; 1988 Feb; 10(1):28-35. PubMed ID: 2459984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotypic heterogeneity of nodular hidradenoma. Immunohistochemical analysis with emphasis on cytokeratin expression.
    Biernat W; Kordek R; Woźniak L
    Am J Dermatopathol; 1996 Dec; 18(6):592-6. PubMed ID: 8989931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eccrine ductal and acrosyringeal differentiation of the breast epithelium--a lesion associated with some metaplastic breast carcinomas.
    Tot T
    Virchows Arch; 2006 Nov; 449(5):565-71. PubMed ID: 17016720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypertrophic eccrine glands in eccrine angiomatous hamartoma produce gross cystic disease fluid protein 15.
    Tanaka M; Shimizu S; Miyakawa S
    Dermatology; 2000; 200(4):336-7. PubMed ID: 10894969
    [No Abstract]   [Full Text] [Related]  

  • 16. Syringomatous hyperplasia and eccrine squamous syringometaplasia associated with benoxaprofen therapy.
    Lerner TH; Barr RJ; Dolezal JF; Stagnone JJ
    Arch Dermatol; 1987 Sep; 123(9):1202-4. PubMed ID: 3498441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presence of alpha-lactalbumin, epidermal growth factor, epithelial membrane antigen, and gross cystic disease fluid protein (15,000 daltons) in breast cyst fluid.
    Collette J; Hendrick JC; Jaspar JM; Franchimont P
    Cancer Res; 1986 Jul; 46(7):3728-33. PubMed ID: 3486713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha-lactalbumin and GCDFP-15 as breast tumor markers (an opportunity to study breast tumors functionally).
    Collette J; Van Cauwenberge JR; Le Doussal V; Serilas M; Hustin J; Carlisi A; Dejardin L; Franchimont P
    Int J Rad Appl Instrum B; 1987; 14(4):385-95. PubMed ID: 3654256
    [No Abstract]   [Full Text] [Related]  

  • 19. Gross cystic disease fluid protein-15 as a marker for breast cancer: immunohistochemical analysis of 690 human neoplasms and comparison with alpha-lactalbumin.
    Wick MR; Lillemoe TJ; Copland GT; Swanson PE; Manivel JC; Kiang DT
    Hum Pathol; 1989 Mar; 20(3):281-7. PubMed ID: 2542151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clear cell eccrine carcinomas of the skin. A clinicopathologic study of nine patients.
    Wong TY; Suster S; Nogita T; Duncan LM; Dickersin RG; Mihm MC
    Cancer; 1994 Mar; 73(6):1631-43. PubMed ID: 7512435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.